.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Moodys
Boehringer Ingelheim
Cantor Fitzgerald
Mallinckrodt
Accenture
Medtronic
Harvard Business School
Chubb
Baxter

Generated: September 19, 2017

DrugPatentWatch Database Preview

TOPROL-XL Drug Profile

« Back to Dashboard

What is the patent landscape for Toprol-xl, and when can generic versions of Toprol-xl launch?

Toprol-xl is a drug marketed by Aralez Pharms and is included in one NDA.

The generic ingredient in TOPROL-XL is metoprolol succinate. There are fifty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.

Summary for Tradename: TOPROL-XL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list9
Bulk Api Vendors: see list67
Clinical Trials: see list25
Patent Applications: see list5,850
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOPROL-XL at DailyMed

Pharmacology for Tradename: TOPROL-XL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TOPROL-XL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-001Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-003Jan 10, 1992► Subscribe► Subscribe
Aralez Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Baxter
Colorcon
Chinese Patent Office
Express Scripts
Cantor Fitzgerald
Merck
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot